RPTX

Repare Therapeutics Inc. - Common Shares (RPTX)

About Repare Therapeutics Inc. - Common Shares (RPTX)

Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded by Daniel Durocher, Agnel Sfeir and Frank Sicheri on September 6, 2016 and is headquartered in Saint-Laurent, Canada.

Details

Daily high
$1.59
Daily low
$1.54
Price at open
$1.58
52 Week High
$4.29
52 Week Low
$0.89
Market cap
67.8M
Dividend yield
0.00%
Volume
50,447
Avg. volume
94,921
P/E ratio
-.53

Repare Therapeutics Inc. - Common Shares News

Details

Daily high
$1.59
Daily low
$1.54
Price at open
$1.58
52 Week High
$4.29
52 Week Low
$0.89
Market cap
67.8M
Dividend yield
0.00%
Volume
50,447
Avg. volume
94,921
P/E ratio
-.53